A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Public ClinicalTrials.gov record NCT02849951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of a 12-week Add-on Treatment With LT-02 vs. Placebo in Subjects With Ulcerative Colitis Refractory to Standard Treatment With Mesalamine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Phosphatidylcholine (LT-02) add on treatment is effective and safe for the induction of remission in ulcerative colitis patients refractory to standard treatment with mesalamine
Study identification
- NCT ID
- NCT02849951
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2016 (Type not available)
- Primary completion
- Mar 2019 (Estimated)
- Completion
- Aug 2019 (Estimated)
- Last update posted
- Jun 15, 2017
2016 – 2019
United States locations
- U.S. sites
- 45
- U.S. states
- 23
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Prometheus Site 24 | Phoenix | Arizona | 85018 | — |
| Prometheus Site 10 | Little Rock | Arkansas | 72205 | — |
| Prometheus Site 15 | Chula Vista | California | 91910 | — |
| Prometheus Site 42 | Lancaster | California | 93534 | — |
| Prometheus Site 30 | Oceanside | California | 92056 | — |
| Prometheus Site 28 | Rialto | California | 92377 | — |
| Prometheus Site 2 | Ventura | California | 93003 | — |
| Prometheus Site 27 | Lafayette | Colorado | 80026 | — |
| Prometheus Site 45 | Lone Tree | Colorado | 80124 | — |
| Prometheus Site 35 | Clearwater | Florida | 33756 | — |
| Prometheus Site 17 | Fort Lauderdale | Florida | 33319 | — |
| Prometheus Site 55 | Hialeah | Florida | 33016 | — |
| Prometheus Site 8 | Naples | Florida | 34102 | — |
| Prometheus Site 13 | Naples | Florida | 34110 | — |
| Prometheus Site 36 | Orlando | Florida | 32803 | — |
| Prometheus Site 44 | Orlando | Florida | 32807 | — |
| Prometheus Site 37 | Athens | Georgia | 30607 | — |
| Prometheus Site 11 | Decatur | Georgia | 30033 | — |
| Prometheus Site 53 | Chicago | Illinois | 60624 | — |
| Prometheus Site 54 | Hoffman Estates | Illinois | 60169 | — |
| Prometheus Site 20 | Topeka | Kansas | 66606 | — |
| Prometheus Site 4 | Shreveport | Louisiana | 71105 | — |
| Prometheus Site 5 | Chevy Chase | Maryland | 20815 | — |
| Prometheus Research Site 1 | Brockton | Massachusetts | 02379 | — |
| Prometheus Site 6 | Chesterfield | Michigan | 48047 | — |
| Prometheus Site 51 | Southfield | Michigan | 48034 | — |
| Prometheus Site 48 | Wyoming | Michigan | 49519 | — |
| Prometheus Site 31 | Plymouth | Minnesota | 55446 | — |
| Prometheus Site 40 | St Louis | Missouri | 63128 | — |
| Prometheus Site 21 | Lebanon | New Hampshire | 03756 | — |
| Prometheus Site 22 | Great Neck | New York | 11021 | — |
| Prometheus Site 33 | Poughkeepsie | New York | 12601 | — |
| Prometheus Site 26 | The Bronx | New York | 10467 | — |
| Prometheus Site 41 | Greenville | North Carolina | 27834 | — |
| Prometheus Site 32 | Kinston | North Carolina | 28501 | — |
| Prometheus Site 43 | Columbia | South Carolina | 29203 | — |
| Prometheus Site 7 | Rapid City | South Dakota | 57701 | — |
| Prometheus Site 49 | Houston | Texas | 77090 | — |
| Prometheus Site 39 | Humble | Texas | 77338 | — |
| Prometheus Site 47 | San Antonio | Texas | 78229 | — |
| Prometheus Site 9 | San Antonio | Texas | 78229 | — |
| Prometheus Site 23 | Orem | Utah | 84058 | — |
| Prometheus Site 25 | Salt Lake City | Utah | 84107 | — |
| Prometheus Site 34 | Charlottesville | Virginia | 22911 | — |
| Prometheus Site 12 | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02849951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2017 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02849951 live on ClinicalTrials.gov.